BARIATRIC SURGERY FOR FERTILITY-SPARING TREATMENT OF ATYPICAL HYPERPLASIA AND GRADE 1 CANCER OF THE ENDOMETRIUM (B-FIERCE)

Registry ID

NCT04008563 (19-5487)

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

UNIVERSITY HEALTH NETWORK

Start date

2024-06-27

Last update

2021-02-19

Conditions

• ENDOMETRIAL CANCER
• INFERTILITY

Related clinical trials

• A RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY TO INVESTIGATE GSK5733584 COMPARED WITH CHEMOTHERAPY IN PARTICIPANTS WITH RECURRENT ENDOMETRIAL CANCER
• A PHASE 3 RANDOMIZED, OPEN-LABEL STUDY OF RINATABART SESUTECAN (RINA-S) VERSUS TREATMENT OF INVESTIGATOR’S CHOICE (IC) IN PATIENTS WITH ENDOMETRIAL CANCER AFTER PLATINUM-BASED CHEMOTHERAPY AND PD(L)-1 THERAPY
• Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
• A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL TRIAL OF TRASTUZUMAB DERUXTECAN VERSUS STANDARD OF CARE CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY AS ADJUVANT TREATMENT FOR HER2-EXPRESSING (IHC 3+/2+) ENDOMETRIAL CANCER (DESTINY-ENDOMETRIAL02/ GOG-3122/ENGOT-EN30/GINECO)
• MENOPUR AND REKOVELLE COMBINATION STUDY VERSION 2.0
• A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY TO COMPARE THE EFFICACY AND SAFETY OF SACITUZUMAB TIRUMOTECAN IN COMBINATION WITH PEMBROLIZUMAB VERSUS PEMBROLIZUMAB ALONE AS FIRST-LINE MAINTENANCE TREATMENT IN PARTICIPANTS WITH MISMATCH REPAIR PROFICIENT ENDOMETRIAL CANCER (TROFUSE-033/GOG-3119/ENGOT-EN29)

View on source registry